Please ensure Javascript is enabled for purposes of website accessibility

Genmab A/S(GMAB)

Nasdaq Global Select

GMAB
Genmab A/S Stock Quote
$36.44 -$0.80 -2.1%
Price as of August 16, 2022, 3:00 p.m. ET View Interactive GMAB Charts

Genmab has developed multiple technologies for creating antibody-based drugs, generates revenue through royalties on partner-produced drugs, and has a robust pipeline to feed future growth.

Interactive Chart


Compare GMAB Stock to Peers


Symbol Last Price Market Cap % Δ 1 Yr % Δ 5 Yr
GMAB
Genmab A/S
$36.44 $24B -19.6% 72.2%
ILMN
$219.83 $35B -56.8% 16.7%
BMY
$74.13 $158B 11.9% 50.7%
EXEL
$19.51 $6B 4.9% -27.6%
GILD
$66.33 $83B -3.4% 9.0%

News & Analysis: Genmab A/S

All

Earnings



Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.